- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Incorrect Data Set Used for Analyses
Correction to the Original Research article “Behavior-Based Diabetes Management: Impact on Care, Hospitalizations, and Costs” published in the March 2021 issue of The American Journal of Managed Care®.
Am J Manag Care. 2022;28(4):192. https://doi.org/10.37765/ajmc.2022.88863
In the Original Research article “Behavior-Based Diabetes Management: Impact on Care, Hospitalizations, and Costs” published in the March 2021 issue of The American Journal of Managed Care®, there was an error in the data set that the authors used to conduct analyses of the propensity-matched cohorts. An inadvertent coding error occurred in the reconstruction of the data set from administrative claims before the data set was provided to the authors’ independent statistical consultant for analysis. The authors have rerun the analyses with the corrected data and updated the Data Analysis and Results sections of the text, as well as the tables and the eAppendix.
The article was corrected online.
REFERENCE
Ahern DK, Aberger EW, Wroblewski JP, et al. Behavior-based diabetes management: impact on care, hospitalizations, and costs. Am J Manag Care. 2021;27(3):96-102. doi:10.37765/ajmc.2021.88597
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
Managed Care Reflections: Insights From Richard J. Gilfillan, MD; and Donald M. Berwick, MD, MPP
February 20th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes reflections from a thought leader on what has changed over the past 3 decades and what’s next for managed care. The February issue features a retrospective by Richard J. Gilfillan, MD, former director of the Center for Medicare and Medicaid Innovation; and Donald M. Berwick, MD, MPP, former administrator of CMS.
Read More
Medical Policy Determinations for Pharmacogenetic Tests Among US Health Plans
February 10th 2025This analysis demonstrated significant variability in medical policy determinations and evidence cited for clinically relevant pharmacogenetic tests among major US health insurers and laboratory benefit managers.
Read More
